Phase II

Phase II studies are most often conducted in a small target population using a placebo (an inactive substance) to compare with the study medication. These well-controlled studies are also double-blinded-neither the research site nor the study participant knows which medication group the participant has been randomly assigned. Phase II studies enable pharmaceutical companies to decide if the new medication is more beneficial compared to a placebo, while continuously monitoring potential adverse effects.